MAUNA KEA TECHNOLOGIES (0P5I) Price & Analysis

0P5I Stock Chart & Stats

€0.10€0.00(1.04%)

At close: Oct 30 4:00 PM EDT

Day’s Range: EUR 0.10 - EUR 0.10
52-Week Range: EUR 0.07 - EUR 0.23
Previous Close: EUR 0.10
Volume: 1,681
Average Volume (3M): 974
Market Cap: EUR 18.94M
Enterprise Value: EUR 39.82M
Total Cash (Recent Filing): EUR 2.35M
Total Debt (Recent Filing): EUR 11.83M
Price to Earnings (P/E): 1.5
Beta: 2.19
Next Earnings: Apr 22, 2027
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Bulls Say, Bears Say

Bulls Say

Revenue Rebound

The sharp 2025 revenue rebound shows that demand for Cellvizio can recover meaningfully after a weak period. If commercial adoption and procedure activity continue improving, higher scale could support better operating leverage and strengthen the platform’s market position over the next several quarters.

Strong Gross Margin

A consistently high gross margin indicates that Cellvizio and related consumables retain substantial value relative to direct costs. This provides an attractive foundation for future profitability if revenue expands and fixed operating expenses become better absorbed across the installed technology base.

Debt Reduction

The substantial reduction in total debt is a meaningful balance-sheet improvement and may lower financing pressure compared with the prior year. Deleveraging can preserve more future cash for commercial investment and reduce the burden of refinancing, even though overall financial flexibility remains constrained.

Bears Say

Deep Operating Losses

The deeply negative operating margin shows that the core business is not yet covering its operating cost base, despite the revenue rebound and strong gross margin. Without sustained cost improvement or much greater scale, ongoing losses could continue consuming resources and delay a durable path to profitability.

Persistent Cash Burn

Negative operating and free cash flow indicate that reported business activity is still not funding ongoing operations. Continued cash burn may require external funding or balance-sheet actions, limiting financial resilience and potentially restricting investment in sales, clinical evidence, and product expansion.

Negative Shareholders’ Equity

Persistent negative equity reflects accumulated deficits and leaves the company with limited balance-sheet flexibility. This weak capital position heightens solvency and refinancing risk, while also making it harder to absorb further operating losses or finance growth without additional capital support.

MAUNA KEA TECHNOLOGIES News

Mauna Kea’s Revenue Climbs on International Growth as U.S. Salesforce Rebuilds

MAUNA KEA TECHNOLOGIES ( ($FR:ALMKT) ) has shared an announcement. Mauna Kea Technologies reported nine-month 2026 revenue of €4.4 million, up 24% at constant exchange rates, driven by a 17%

1w ago1MK 0P5I

Mauna Kea lifts core revenue on CellTolerance momentum and extends cash runway to 2027

MAUNA KEA TECHNOLOGIES ( ($FR:ALMKT) ) just unveiled an announcement. Mauna Kea Technologies reported a 37% rise in product and service revenue to €3.2 million in the first half of

3w ago1MK 0P5I

Mauna Kea Discloses Updated Share Capital and Voting Rights Structure

MAUNA KEA TECHNOLOGIES ( ($FR:ALMKT) ) has shared an update. Mauna Kea Technologies reported that as of 30 September 2026, its share capital comprised 199,066,710 shares listed on Euronext Growth

3w ago1MK 0P5I

Mauna Kea Technologies Updates Share Capital and Voting Rights After New Share Issuance

An announcement from MAUNA KEA TECHNOLOGIES ( ($FR:ALMKT) ) is now available. Mauna Kea Technologies reported updated share capital and voting rights as of August 31, 2026, with 198,626,997 shares

1M ago1MK 0P5I

Independent Meta-Analysis Strengthens Case for Mauna Kea’s Cellvizio in GI Cancer

An announcement from MAUNA KEA TECHNOLOGIES ( ($FR:ALMKT) ) is now available. A landmark independent systematic review and meta-analysis from Korea’s National Evidence-Based Healthcare Collaborating Agency has validated probe-based confocal

2M ago1MK 0P5I

Mauna Kea Technologies Updates Share Capital and Voting Rights

An update from MAUNA KEA TECHNOLOGIES ( ($FR:ALMKT) ) is now available. Mauna Kea Technologies reported that as of July 31, 2026, its share capital comprised 195,296,487 shares in circulation,

2M ago1MK 0P5I

Mauna Kea boosts pancreatic cyst diagnosis accuracy with Cellvizio and AI

An announcement from MAUNA KEA TECHNOLOGIES ( ($FR:ALMKT) ) is now available. Mauna Kea Technologies reported new clinical evidence from two peer-reviewed gastroenterology studies underscoring the value of its Cellvizio

3M ago1MK 0P5I

Mauna Kea Technologies Posts Strong H1 2026 Growth, Bolsters Path to Profitability

MAUNA KEA TECHNOLOGIES ( ($FR:ALMKT) ) just unveiled an announcement. Mauna Kea Technologies reported first-half 2026 revenue of €3.2 million, up 44% at constant currency, driven by clinical adoption of

3M ago1MK 0P5I

0P5I FAQ

What was MAUNA KEA TECHNOLOGIES’s price range in the past 12 months?

MAUNA KEA TECHNOLOGIES lowest share price was €0.07 and its highest was €0.23 in the past 12 months.

What is MAUNA KEA TECHNOLOGIES’s market cap?

MAUNA KEA TECHNOLOGIES’s market cap is €18.94M.

When is MAUNA KEA TECHNOLOGIES’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were MAUNA KEA TECHNOLOGIES’s earnings last quarter?

MAUNA KEA TECHNOLOGIES released its earnings results on Oct 08, 2026. The company reported -€0.026 earnings per share for the quarter.

Is MAUNA KEA TECHNOLOGIES overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does MAUNA KEA TECHNOLOGIES pay dividends?

MAUNA KEA TECHNOLOGIES does not currently pay dividends.

What is MAUNA KEA TECHNOLOGIES’s EPS estimate?

MAUNA KEA TECHNOLOGIES’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does MAUNA KEA TECHNOLOGIES have?

MAUNA KEA TECHNOLOGIES has 195,260,220 shares outstanding.

What happened to MAUNA KEA TECHNOLOGIES’s price movement after its last earnings report?

MAUNA KEA TECHNOLOGIES reported an EPS of -€0.026 in its last earnings report. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of MAUNA KEA TECHNOLOGIES?

Currently, no hedge funds are holding shares in GB:0P5I

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description